. Author manuscript; available in PMC: 2021 Dec 2.

Published in final edited form as: Liver Int. 2020 Mar 8;40(5):1201–1210. doi: 10.1111/liv.14409

Table 1.

Frequencies of HCC causes and assigned predominant cause for 2,594 Florida Cancer Data System-Agency Health Care Administration (discharge data) matched cases in Florida, 2014–2015.

	n (%)	Predominant Cause^†
HCV	379 (14.6%)	HCV (48.0%)
HCV+Metabolic^‡	442 (17.0%)
HCV+ALD	219 (8.4%)
HCV+ALD+Metabolic^‡	180 (6.9%)
HCV+HBV+Metabolic^‡	10 (0.4%)
HCV+HBV+ALD	6 (0.2%)
HCV+HBV	5 (0.2%)
HCV+HBV+ALD+Metabolic^‡	3 (0.1%)
HBV	45 (1.7%)	HBV (3.9%)
HBV+Metabolic^‡	39 (1.5%)
HBV+ALD	9 (0.3%)
HBV+ALD+Metabolic^‡	8 (0.3%)
Genetic, Biliary, Autoimmune	21 (0.8%)	Other^§ (1.0%)
Genetic + Metabolic^‡	5 (0.2%)	Other^§ (1.0%)
ALD	158 (6.1%)	ALD (14.4%)
ALD+Metabolic^‡	215 (8.3%)	ALD (14.4%)
Metabolic^‡	727 (28.0%)	Metabolic^‡ (28.0%)
Cryptogenic	123 (4.7%)	Cryptogenic (4.7%)

^†.

In descending order according to the classification by Beste et al. ref# 21

^‡.

Metabolic includes NAFLD, obesity, type 2 diabetes, metabolic syndrome

^§.

Other includes genetic, biliary, autoimmune